• Featured Product
  • KD/KO验证

QSOX1/Quiescin Q6 Polyclonal antibody

QSOX1/Quiescin Q6 Polyclonal Antibody for WB, IHC, IF-P, IP, ELISA
Cat No. 12713-1-AP

产品说明书

宿主/亚型

Rabbit / IgG

种属反应性

human, mouse, rat and More (1)

应用

WB, IHC, IF-P, IP, ELISA and More (2)

QSOX1, UNQ2520/PRO6013, QSCN6, Q6, hQSOX

缓冲液配方:  PBS and Azide
PBS and Azide
偶联物:  Unconjugated
Unconjugated
规格: 

-/ -


经过测试的应用

Positive WB detected inSW 1990 cells, mouse heart tissue, human placenta tissue, rat heart tissue
Positive IP detected inSW 1990 cells
Positive IHC detected inhuman liver cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF-P detected inmouse colon tissue
Planning an IHC experiment? We recommend our IHCeasy QSOX1/Quiescin Q6 Ready-To-Use IHC Kit. QSOX1/Quiescin Q6 primary antibody included.

推荐稀释比

应用推荐稀释比
Western Blot (WB)WB : 1:500-1:2000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochemistry (IHC)IHC : 1:50-1:500
Immunofluorescence (IF)-PIF-P : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

12713-1-AP targets QSOX1/Quiescin Q6 in WB, IHC, IF-P, IP, CoIP, ELISA applications and shows reactivity with human, mouse, rat samples.

经测试应用 WB, IHC, IF-P, IP, ELISA Application Description
文献引用应用WB, IHC, IF, CoIP
经测试反应性 human, mouse, rat
文献引用反应性human, mouse, rat, hamster
免疫原 QSOX1/Quiescin Q6 fusion protein Ag3396 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Polyclonal
产品类型 Antibody
全称 quiescin Q6 sulfhydryl oxidase 1
别名 QSOX1, UNQ2520/PRO6013, QSCN6, Q6, hQSOX
计算分子量 747 aa, 83 kDa
观测分子量 66-83kDa
GenBank蛋白编号BC017692
基因名称 QSOX1
Gene ID (NCBI) 5768
RRIDAB_2173314
偶联类型 Unconjugated
形式 Liquid
纯化方式Antigen affinity purification
UNIPROT IDO00391
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

QSOX1(Sulfhydryl oxidase 1) catalyzes the oxidation of sulfhydryl groups in peptide and protein thiols to disulfides with the reduction of oxygen to hydrogen peroxide.It has two isoforms with the molecular weight of 67 kda and 83 kDa,respectively. It is detected a band of 95 Kda in HT1080 cell lines (PMID:17331072).Isoform 1 is expressed on golgi apparatus membrane and isoform 2 is secreted (PMID:10708601). The isoform1(QSOX1a) is the full length of QSOX1, approximately 78 kd; and the isoform2(QSOX1b) is the splicing form, approximately 62kd(PMID:14633699; 2496424). QSOX1 is highly expressed in tumor cell lines but is not expressed in adjacent normal cells (PMID:21989104).

实验方案

Product Specific Protocols
WB protocol for QSOX1/Quiescin Q6 antibody 12713-1-APDownload protocol
IHC protocol for QSOX1/Quiescin Q6 antibody 12713-1-APDownload protocol
IF protocol for QSOX1/Quiescin Q6 antibody 12713-1-APDownload protocol
IP protocol for QSOX1/Quiescin Q6 antibody 12713-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

发表文章

SpeciesApplicationTitle
humanIHC

Redox Biol

Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activation.

Authors - Jialei Sun
WB

Antioxid Redox Signal

The Emerging Role of QSOX1 in Cancer.

Authors - Douglas F Lake
humanIHC

Breast Cancer Res

High expression of QSOX1 reduces tumorogenesis, and is associated with a better outcome for breast cancer patients.

Authors - Pernodet Nicolas N
humanWB,IHC

Breast Cancer Res

Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer.

Authors - Katchman Benjamin A BA
humanIHC

Mod Pathol

QSOX1 expression is associated with aggressive tumor features and reduced survival in breast carcinomas.

Authors - Gøril Knutsvik
humanIHC

Oncotarget

Reduced QSOX1 enhances radioresistance in nasopharyngeal carcinoma.

Authors - Lei Zhou
Loading...